Green Tea Leaf Extract Decaffeinated: Clinical Trials

2 trials of Green Tea Leaf Extract Decaffeinated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 31Completed 1

Follow Green Tea Leaf Extract Decaffeinated: new trials by email Literature Review of Green Tea Leaf Extract Decaffeinated trials Research Report on Green Tea Leaf Extract Decaffeinated

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain
Green Tea Leaf Extract Decaffeinated, Placebo Control - Neuropathic Pain, Cancer Treatment
Phase 1Not yet recruitingUniversity of Alabama at Birmingham202026-09-302026-08-21
Effect of Green Tea on Obese Pediatrics With Prediabetes
Green Tea Leaf Extract Decaffeinated, Metformin Hydrochloride 500 MG - PreDiabetes
Phase 3CompletedAin Shams University902023-11-122026-01-06

Conditions studied

Insulin Resistance (1)  ·  Neuralgia (1)  ·  Prediabetic State (1)

Sponsors

Ain Shams University (1)  ·  University of Alabama at Birmingham (1)

Countries

Egypt (1)  ·  United States (1)

Top investigators

Michael Daniel, PhD (1)